Hematopoietic Stem Cells Transplantation Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Hematopoietic Stem Cells Transplantation Market in 2025 is assessed at USD 3.29 billion. The global market size surpassed USD 3.05 billion in 2024 and is projected to witness a CAGR of over 9.7%, crossing USD 10.16 billion revenue by 2037. North America is forecast to see USD 4.06 billion by 2037, due to strong key player presence and mergers in stem cell therapies.
The reason behind the growth is impelled by the rising prevalence of leukemia. Hematopoietic stem cell transplantation can be used to treat certain cancers, including leukemia, as stem cells aid in immune system restoration and the stimulation of new bone marrow development that may benefit patients to regenerate healthy bone marrow. In 2020, there were more than 474,510 new cases of leukemia reported globally.
The growing advancements in stem cell transplantation technology are believed to fuel the market growth. For instance, in February 2023, Lund University in Sweden discovered that stem cells have shown promise in treating the inflammation that underlies heart failure as it was found that patients receiving the treatment had more than 55% lower risk of heart attack or stroke, and the benefits rose to over 70% in patients with high inflammation since the treatment may decrease plaque instability.
